Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Younes, Anas, Dr, Berdeja, Jesus G, MD, Patel, Manish R, MD, Flinn, Ian, MD, Gerecitano, John F, MD, Neelapu, Sattva S, MD, Kelly, Kevin R, MD, Copeland, Amanda R, MSN, Akins, Amy, BSN, Clancy, Myles S, MBA, Gong, Lucy, PharmD, Wang, Jing, PhD, Ma, Anna, MS, Viner, Jaye L, MD, Oki, Yasuhiro, MD
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction
Polly, David W, Swofford, John, Whang, Peter G, Frank, Clay J, Glaser, John A, Limoni, Robert P, Cher, Daniel J, Wine, Kathryn D, Sembrano, Jonathan N
Published in International journal of spine surgery (01.01.2016)
Published in International journal of spine surgery (01.01.2016)
Get full text
Journal Article
Phase 1 safety and dose escalation of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K in relapsed or refractory lymphoma and multiple myeloma
Younes, Anas, Berdeja, Jesus G., Patel, Manish R., Flinn, Ian, Gerecitano, John F., Neelapu, Sattva S., Kelly, Kevin R., Copeland, Amanda R., Akins, Amy, Clancy, Myles S., Gong, Lucy, Wang, Jing, Ma, Anna, Viner, Jaye L., Oki, Yasuhiro
Published in The lancet oncology (31.03.2016)
Published in The lancet oncology (31.03.2016)
Get full text
Journal Article
Phase 1 Trial Testing Single Agent CUDC-907, a Novel, Oral Dual Inhibitor of Histone Deacetylase (HDAC) and PI3K: Initial Assessment of Patients with Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL), Including Double Expressor (DE) Lymphoma
Younes, Anas, Berdeja, Jesus G., Patel, Manish R., Kelly, Kevin R., Flinn, Ian W., Gerecitano, John F, Neelapu, Sattva S., Copeland, Amanda R., Akins, Amy, Clancy, Myles, Ma, Anna, Sun, Kaiming, Tian, Ze, Wang, Jing, Viner, Jaye, Oki, Yasuhiro
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article